Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research report report published on Friday. The firm issued a sell rating on the biotechnology company’s stock. CYCC has been the subject of several other reports. Roth Mkm lifted their price target on shares of Cyclacel Pharmaceuticals from $16.00 to $21.00 […]
More Stories
Stonegate Investment Group LLC Cuts Stake in American Electric Power Company, Inc. (NASDAQ:AEP)
Stonegate Investment Group LLC trimmed its position in shares of American Electric Power Company, Inc. (NASDAQ:AEP – Free Report) by...
Stonegate Investment Group LLC Boosts Stock Position in Laboratory Co. of America Holdings (NYSE:LH)
Stonegate Investment Group LLC boosted its position in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) by...
ITT (NYSE:ITT) Price Target Raised to $167.00
ITT (NYSE:ITT – Free Report) had its price target raised by Stifel Nicolaus from $157.00 to $167.00 in a report...
Wells Fargo & Company Raises ONE Gas (NYSE:OGS) Price Target to $82.00
ONE Gas (NYSE:OGS – Free Report) had its target price hoisted by Wells Fargo & Company from $80.00 to $82.00...
Evercore ISI Raises J.B. Hunt Transport Services (NASDAQ:JBHT) Price Target to $185.00
J.B. Hunt Transport Services (NASDAQ:JBHT – Free Report) had its price target boosted by Evercore ISI from $183.00 to $185.00...
Acelyrin (NASDAQ:SLRN) Price Target Raised to $15.00
Acelyrin (NASDAQ:SLRN – Free Report) had its price objective lifted by Wells Fargo & Company from $13.00 to $15.00 in...